Literature DB >> 27534519

Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis.

L Peyrin-Biroulet1, A Germain2, A S Patel3, J O Lindsay4.   

Abstract

BACKGROUND: Colectomy for ulcerative colitis is associated with short- and long-term complications. Estimates of the frequency of such complications are variable and may have changed since the introduction of biological therapy. Understanding the true burden of surgical complications is important to clinicians in assessing risks and benefits of colectomy vs. continued medical therapy. AIM: To ascertain the outcomes of colectomy and ileal pouch surgery in patients with ulcerative colitis in the biologics era.
METHODS: Embase, MEDLINE and The Cochrane Library were searched for studies (2002-2015) reporting the outcomes of colorectal procedures (total and subtotal colectomy, IPAA with J-, S-, W-pouch) in adults with ulcerative colitis. Conferences proceedings (2011-2015) were hand-searched.
RESULTS: We identified 28 studies (20,801 patients) reporting outcomes from procedures conducted from 2002-2015. Early complications (≤30 days post-operatively), reported in 10 studies, occurred in 9-65% of patients with ulcerative colitis; late complications (>30 days post-operatively) occurred in 17-55% of patients. Most frequent short-term complications: infectious complications and ileus (mean incidence 20% and 18%). Most frequent long-term complications: pouchitis, faecal incontinence and small bowel obstruction (mean incidence 29%, 21% and 17%). Rates of early infection and late pouch failure decreased from 22% and 13% in 2002-2009 to 11% and 2% in 2010-2015. The mean incidence of post-operative mortality was 1.0% across 11 studies.
CONCLUSIONS: Early and late complications arise in about one-third of patients undergoing surgery for ulcerative colitis. While colorectal surgical procedures are recommended for a specific group of patients, the post-operative complications associated with these procedures should not be underestimated.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27534519     DOI: 10.1111/apt.13763

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  23 in total

1.  Refractory Chronic Pouchitis and Autoimmune Hemolytic Anemia Successfully Treated with Vedolizumab.

Authors:  Diana Martins; Paula Ministro; Américo Silva
Journal:  GE Port J Gastroenterol       Date:  2018-02-14

2.  Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis.

Authors:  Edward L Barnes; Hans H Herfarth; Robert S Sandler; Wenli Chen; Elizabeth Jaeger; Van M Nguyen; Amber R Robb; Michael D Kappelman; Christopher F Martin; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2017-07       Impact factor: 5.325

Review 3.  Preventing disability in inflammatory bowel disease.

Authors:  Patrick B Allen; Corinne Gower-Rousseau; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Therap Adv Gastroenterol       Date:  2017-10-16       Impact factor: 4.409

Review 4.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis.

Authors:  G Pellino; D S Keller; G M Sampietro; M Carvello; V Celentano; C Coco; F Colombo; A Geccherle; G Luglio; M Rottoli; M Scarpa; G Sciaudone; G Sica; L Sofo; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-02       Impact factor: 3.781

5.  Patient Acuity and Operative Technique Associated with Post-Colectomy Mortality Across New York State: an Analysis of 160,792 Patients over 20 years.

Authors:  Ryan Lamm; Steven N Mathews; Jie Yang; Jihye Park; Mark Talamini; Aurora D Pryor; Dana Telem
Journal:  J Gastrointest Surg       Date:  2017-03-15       Impact factor: 3.452

6.  Risk of post-operative surgical site infections after vedolizumab vs anti-tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease.

Authors:  K T Park; L Sceats; M Dehghan; A W Trickey; A Wren; J J Wong; R Bensen; B N Limketkai; K Keyashian; C Kin
Journal:  Aliment Pharmacol Ther       Date:  2018-06-07       Impact factor: 8.171

7.  Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis.

Authors:  Grace C Lee; Sarah E Deery; Hiroko Kunitake; Caitlin W Hicks; Adriana G Olariu; Lieba R Savitt; Ashwin N Ananthakrishnan; Rocco Ricciardi; Richard A Hodin; Liliana G Bordeianou
Journal:  Int J Colorectal Dis       Date:  2019-01-04       Impact factor: 2.571

8.  Toward a More Sensitive Endpoint for Assessing Postoperative Complications in Patients with Inflammatory Bowel Disease: a Comparison Between Comprehensive Complication Index (CCI) and Clavien-Dindo Classification (CDC).

Authors:  Feng Zhu; Dengyu Feng; Tenghui Zhang; Lili Gu; Weiming Zhu; Zhen Guo; Yi Li; Jianfeng Gong; Ning Li; Jieshou Li
Journal:  J Gastrointest Surg       Date:  2018-05-15       Impact factor: 3.452

Review 9.  Contemporary Management of Ulcerative Colitis.

Authors:  Rohini Vanga; Millie D Long
Journal:  Curr Gastroenterol Rep       Date:  2018-03-27

10.  Delayed Ileal Pouch Anal Anastomosis Has a Lower 30-Day Adverse Event Rate: Analysis From the National Surgical Quality Improvement Program.

Authors:  Bharati Kochar; Edward L Barnes; Anne F Peery; Katherine S Cools; Joseph Galanko; Mark Koruda; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2018-07-12       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.